A A Reszka

2.7k total citations · 1 hit paper
12 papers, 2.3k citations indexed

About

A A Reszka is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, A A Reszka has authored 12 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Cell Biology. Recurrent topics in A A Reszka's work include Bone health and treatments (4 papers), Cellular Mechanics and Interactions (4 papers) and Bone Metabolism and Diseases (4 papers). A A Reszka is often cited by papers focused on Bone health and treatments (4 papers), Cellular Mechanics and Interactions (4 papers) and Bone Metabolism and Diseases (4 papers). A A Reszka collaborates with scholars based in United States and United Kingdom. A A Reszka's co-authors include Gideon A. Rodan, John Fisher, Gregg Wesolowski, Yusuke Hayashi, E G Krebs, Rony Seger, Helmut Glantschnig, C D Diltz, E H Fischer and R.G.G. Russell and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

A A Reszka

12 papers receiving 2.2k citations

Hit Papers

Alendronate mechanism of action: geranylgeraniol, an inte... 1999 2026 2008 2017 1999 100 200 300 400 500

Peers

A A Reszka
Archana Sanjay United States
Lorraine Lipfert United States
C H Heldin Sweden
Mario N. Lioubin United States
Shawn M. Ellerbroek United States
Deniz Toksoz United States
Manuel A. Pallero United States
Archana Sanjay United States
A A Reszka
Citations per year, relative to A A Reszka A A Reszka (= 1×) peers Archana Sanjay

Countries citing papers authored by A A Reszka

Since Specialization
Citations

This map shows the geographic impact of A A Reszka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A A Reszka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A A Reszka more than expected).

Fields of papers citing papers by A A Reszka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A A Reszka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A A Reszka. The network helps show where A A Reszka may publish in the future.

Co-authorship network of co-authors of A A Reszka

This figure shows the co-authorship network connecting the top 25 collaborators of A A Reszka. A scholar is included among the top collaborators of A A Reszka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A A Reszka. A A Reszka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Luegmayr, Eva, Helmut Glantschnig, Gregg Wesolowski, et al.. (2004). Osteoclast formation, survival and morphology are highly dependent on exogenous cholesterol/lipoproteins. Cell Death and Differentiation. 11(S1). S108–S118. 115 indexed citations
2.
Leu, Chih‐Tai, Su Jane Rutledge, Robert L. Vogel, et al.. (2004). Partial agonist/antagonist properties of androstenedione and 4-androsten-3β,17β-diol. The Journal of Steroid Biochemistry and Molecular Biology. 91(4-5). 247–257. 43 indexed citations
3.
Glantschnig, Helmut, John Fisher, Gregg Wesolowski, Gideon A. Rodan, & A A Reszka. (2003). M-CSF, TNFα and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase. Cell Death and Differentiation. 10(10). 1165–1177. 287 indexed citations
4.
Rodan, Gideon A., et al.. (2001). Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis. Bone. 29(6). 553–559. 158 indexed citations
5.
Fisher, John, Michael J. Rogers, Steven P. Luckman, et al.. (1999). Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. Proceedings of the National Academy of Sciences. 96(1). 133–138. 570 indexed citations breakdown →
7.
Lilienbaum, Alain, A A Reszka, Alan F. Horwitz, & Christine E. Holt. (1995). Chimeric Integrins Expressed in Retinal Ganglion Cells Impair Process Outgrowth in Vivo. Molecular and Cellular Neuroscience. 6(2). 139–152. 56 indexed citations
8.
Reszka, A A, Rony Seger, C D Diltz, E G Krebs, & E H Fischer. (1995). Association of mitogen-activated protein kinase with the microtubule cytoskeleton.. Proceedings of the National Academy of Sciences. 92(19). 8881–8885. 316 indexed citations
10.
Reszka, A A, et al.. (1992). Identification of amino acid sequences in the integrin beta 1 cytoplasmic domain implicated in cytoskeletal association. The Journal of Cell Biology. 117(6). 1321–1330. 238 indexed citations
11.
Sundberg, John P., et al.. (1991). An Oral Papillomavirus that Infected One Coyote and Three Dogs. Veterinary Pathology. 28(1). 87–88. 12 indexed citations
12.
Hayashi, Yusuke, Beatrice Haimovich, A A Reszka, David Boettiger, & Alan F. Horwitz. (1990). Expression and function of chicken integrin beta 1 subunit and its cytoplasmic domain mutants in mouse NIH 3T3 cells.. The Journal of Cell Biology. 110(1). 175–184. 216 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026